Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $346.5000 (1.69%) ($340.9603 - $349.9700) on Fri. Jan. 27, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.85% (three month average) | | RSI | 43 | | Latest Price | $346.5000(1.69%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.9% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.3% a week on average for past two weeks. | | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(49%) XBI(44%) QQQ(42%) IVW(41%) | | Factors Impacting REGN price | REGN will decline at least -1.425% in a week (0% probabilities).
VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) SHY(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.425% (StdDev 2.85%) | | Hourly BBV | 0 () | | Intraday Trend | 1.2% | | | | | |
|
| Resistance Level | $362.36 | | 5 Day Moving Average | $347.7(-0.35%) | | 10 Day Moving Average | $355.36(-2.49%) | | 20 Day Moving Average | $362.36(-4.38%) | | To recent high | -22.1% | | To recent low | 3.1% | | Market Cap | $36.739b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |